Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Persistent infection with neurotropic herpes viruses and cognitive impairment.

Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL.

Psychol Med. 2013 May;43(5):1023-31. doi: 10.1017/S003329171200195X. Epub 2012 Sep 14.

PMID:
22975221
2.

Exposure to herpes simplex virus, type 1 and reduced cognitive function.

Thomas P, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN.

J Psychiatr Res. 2013 Nov;47(11):1680-5. doi: 10.1016/j.jpsychires.2013.07.010. Epub 2013 Aug 3.

3.

The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.

Fruchter E, Goldberg S, Fenchel D, Grotto I, Ginat K, Weiser M.

Schizophr Res. 2015 Oct;168(1-2):292-6. doi: 10.1016/j.schres.2015.08.036. Epub 2015 Sep 8.

PMID:
26362735
4.

Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.

Dickerson F, Stallings C, Sullens A, Origoni A, Leister F, Krivogorsky B, Yolken R.

Brain Behav Immun. 2008 Oct;22(7):1103-7. doi: 10.1016/j.bbi.2008.04.156. Epub 2008 Jun 20.

PMID:
18571372
5.

Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.

Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH.

Arch Gen Psychiatry. 2003 May;60(5):466-72.

PMID:
12742867
6.

Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A.

Ethiop Med J. 2011 Jul;49(3):211-20.

PMID:
21991754
7.

Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects.

Wiener H, Klei L, Calkins M, Wood J, Nimgaonkar V, Gur R, Bradford LD, Richard J, Edwards N, Savage R, Kwentus J, Allen T, McEvoy J, Santos A, Gur R, Devlin B, Go R.

Schizophr Bull. 2013 Mar;39(2):464-71. doi: 10.1093/schbul/sbr161. Epub 2012 Jan 10.

8.

Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.

Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB.

Schizophr Res. 2011 May;128(1-3):61-5. doi: 10.1016/j.schres.2011.01.020. Epub 2011 Feb 24.

PMID:
21353483
9.
10.

Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study.

Aarnisalo J, Ilonen J, Vainionpää R, Volanen I, Kaitosaari T, Simell O.

Scand J Infect Dis. 2003;35(10):750-3.

PMID:
14606615
11.

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1137-48. doi: 10.1093/schbul/sbs046. Epub 2012 Apr 6. Review.

12.

Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH.

Biol Psychiatry. 2004 Mar 15;55(6):588-93.

PMID:
15013827
13.

Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL.

Schizophr Res. 2008 Dec;106(2-3):268-74. doi: 10.1016/j.schres.2008.07.017. Epub 2008 Sep 17.

14.

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.

Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H, Klei L, Gur RC, Bradford LD, Calkins ME, Santos AB, Edwards N, Kwentus J, McEvoy JP, Allen TB, Savage RM, Nasrallah HA, Gur RE, Perry RT, Go RC, Devlin B, Yolken R, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1149-54. doi: 10.1093/schbul/sbs087. Epub 2012 Sep 10.

15.

Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.

Tarter KD, Simanek AM, Dowd JB, Aiello AE.

J Infect Dis. 2014 Mar;209(6):837-44. doi: 10.1093/infdis/jit616. Epub 2013 Nov 18.

16.

Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.

Bolu A, Oznur T, Tok D, Balikci A, Sener K, Celik C, Gulsun M.

Psychiatr Danub. 2016 Jun;28(2):132-8.

17.

Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance.

D'Aiuto L, Prasad KM, Upton CH, Viggiano L, Milosevic J, Raimondi G, McClain L, Chowdari K, Tischfield J, Sheldon M, Moore JC, Yolken RH, Kinchington PR, Nimgaonkar VL.

Schizophr Bull. 2015 Jan;41(1):123-32. doi: 10.1093/schbul/sbu032. Epub 2014 Mar 12.

18.

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.

Schizophr Res. 2012 Jan;134(1):83-8. doi: 10.1016/j.schres.2011.10.003. Epub 2011 Nov 1.

PMID:
22048011
19.

Influence of maternal infections on neonatal acute phase proteins and their interaction in the development of non-affective psychosis.

Blomström Å, Gardner RM, Dalman C, Yolken RH, Karlsson H.

Transl Psychiatry. 2015 Feb 3;5:e502. doi: 10.1038/tp.2014.142.

20.

Supplemental Content

Support Center